BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2459244)

  • 1. Antipeptide antibody specific for the N-terminal of soluble immune response suppressor neutralizes concanavalin A and IFN-induced suppressor cell activity in an in vitro cytotoxic T lymphocyte response.
    Devens BH; Semenuk G; Webb DR
    J Immunol; 1988 Nov; 141(9):3148-55. PubMed ID: 2459244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic identification of specific and nonspecific suppressor T-cell populations involved in the in vivo response to alloantigen.
    Devens BH; Webb DR
    Cell Immunol; 1995 Mar; 161(1):1-7. PubMed ID: 7867074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and initial characterization of concanavalin A- and interferon-induced human suppressor factors: evidence for a human equivalent of murine soluble immune response suppressor (SIRS).
    Schnaper HW; Pierce CW; Aune TM
    J Immunol; 1984 May; 132(5):2429-35. PubMed ID: 6232318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a murine mutant Ras CD8+ CTL peptide epitope variant that possesses enhanced MHC class I binding and immunogenic properties.
    Bristol JA; Schlom J; Abrams SI
    J Immunol; 1998 Mar; 160(5):2433-41. PubMed ID: 9498787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
    Clark DA; Chaput A; Walker C; Rosenthal KL
    J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of the immune response to alloantigen by factors released from ultraviolet-irradiated keratinocytes.
    Ullrich SE; McIntyre BW; Rivas JM
    J Immunol; 1990 Jul; 145(2):489-98. PubMed ID: 2142179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
    Chow KP; Battisto JR
    J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. II. Role of interleukin-1-like factors and of soluble suppressor factors.
    Mellow L; Sabbadini E
    Immunology; 1985 Oct; 56(2):235-43. PubMed ID: 2932383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for histamine type II (H-2) receptor binding in production of the lymphokine, soluble immune response suppressor (SIRS).
    Schnaper HW; Aune TM; Roby RK
    J Immunol; 1987 Aug; 139(4):1185-90. PubMed ID: 2440946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between secreted and cell surface antigen-binding molecules synthesized by T cells. I. Function-related isotypic determinants on T cells defined by antisera to antigen-specific helper and suppressor factors.
    Culbert EJ; Kontiainen S; Feldmann M
    Immunology; 1984 Nov; 53(3):481-90. PubMed ID: 6208146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the activation of cytotoxic T lymphocytes by prostaglandins and antigens.
    Ting CC; Hargrove ME
    J Immunol; 1984 Aug; 133(2):660-6. PubMed ID: 6203973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells.
    Malkovský M; Asherson GL; Chandler P; Colizzi V; Watkins MC; Zembala M
    J Immunol; 1983 Feb; 130(2):785-90. PubMed ID: 6217254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
    Maier T; Holda JH
    J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-like moiety of the monoclonal nonspecific suppressor factor beta is responsible for its activity.
    Nakamura M; Xavier RM; Tanigawa Y
    J Immunol; 1996 Jan; 156(2):532-8. PubMed ID: 8543803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance.
    Good MF; Nossal GJ
    J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigations into the nature of Igh-V region-restricted T cell interactions by using antibodies to antigens on methylcholanthrene-induced sarcomas. I. Analysis of an Igh-V-restricted suppressor-inducer factor.
    Flood PM
    J Immunol; 1985 Mar; 134(3):1665-72. PubMed ID: 2578515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on induction and effector functions of concanavalin A-induced suppressor cells that limit TCGF production.
    Gullberg M; Larsson EL
    J Immunol; 1982 Feb; 128(2):746-50. PubMed ID: 6459384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.